Drug-induced methaemoglobinaemia following elective coronary artery bypass grafting

11Citations
Citations of this article
23Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Dapsone can alter the oxygen carrying capacity of haemoglobin. Some patients are more susceptible to these effects because of genetic factors, comorbidities or peri-operative factors such as anaemia. We present a 57-year-old lady who underwent elective coronary artery bypass grafting. Deterioration in neurological and respiratory condition prompted a review of her drug treatment. A combination of long-term dapsone therapy, co-existing cardiac and respiratory disease, postoperative anaemia and renal impairment contributed to her decompensation, despite a relatively low level of methaemoglobin. Successful management included stopping dapsone therapy, supportive care and administration of ascorbic acid. © 2007 The Authors Journal compilation 2007 The Association of Anaesthetists of Great Britain and Ireland.

Cite

CITATION STYLE

APA

Choi, A., & Sarang, A. (2007). Drug-induced methaemoglobinaemia following elective coronary artery bypass grafting. Anaesthesia, 62(7), 737–740. https://doi.org/10.1111/j.1365-2044.2007.05000.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free